Item 7.01. Regulation FD Disclosure.
On
The Company's updated corporate presentation has been posted to the Company's website, www.aviditybiosciences.com. The Company plans to use its website to disseminate future updates to its corporate presentation and does not intend to file or furnish a Form 8-K alerting investors each time the presentation is updated.
In accordance with General Instruction B.2 of Form 8-K, the information in this Current Report on Form 8-K, including Exhibit 99.1 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") or otherwise subject to the liabilities of that section, and it shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or under the Exchange Act, whether made before or after the date hereof, except as expressly provided by specific reference in such filing.
By filing this Current Report on Form 8-K and furnishing the information in this
Item 7.01, the Company makes no admission as to the materiality of Item 7.01 in
this report or the presentation available on the Company's website. The
information contained in the corporate presentation is summary information that
is intended to be considered in the context of the Company's filings with the
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits Exhibit Number Description 99.1 Slide Presentation 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
--------------------------------------------------------------------------------
© Edgar Online, source